1 |
Park, Y.S., Y.S. Yoon and H.S. Ahn. 2007. Platycodon grandiflorum extract represses up-regulated adipocyte fatty acid binding protein triggered by a high fat feeding in obese rats. World J. Gastroenterol. 7:3493-3499.
DOI
|
2 |
Mueller, C. 2002. Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology 105:1-8.
DOI
|
3 |
Sandborn, W.J. and S.R. Targan. 2002. Biologic therapy of inflammatory bowel disease. Gastroenterology 122:1592-1608.
DOI
|
4 |
Scaldaferri, F., S. Vetrano, M. Sans, V. Arena, G. Straface, E. Stigliano, A. Repici, A. Sturm, A. Malesci, J. Panes, S. Yla-Herttuala, C. Fiocchi and S. Danese. 2009. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136:585-595.
DOI
|
5 |
Taylor, C.T. and S.P. Colgan. 2007. Hypoxia and gastrointestinal disease. J. Mol. Med. 85:1295-1300.
DOI
|
6 |
Wirtz, S., V. Popp, M. Kindermann, K. Gerlach, B. Weigmann, S. Fichtner-Feigl and M.F. Neurath. 2017. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12(7):1295-1309.
DOI
|
7 |
Yashiro, M. 2014. Ulcerative colitis-associated colorectal cancer. World J. Gastroenterol. 28:16389-16397.
DOI
|
8 |
Glover, L.E. and S.P. Colgan. 2011. Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology 140:1748-1755.
DOI
|
9 |
Ardizzone, S. and P.G. Bianchi. 2005. Biologic therapy for inflammatory bowel disease. Drugs 65:2253-2286.
DOI
|
10 |
Cottone, M., S. Renna, I. Modesto and A. Orlando. 2011. Is 5-ASA still the treatment of choice for ulcerative colitis? Curr. Drug Targets 12:1396-1405.
DOI
|
11 |
Eichele, D.D. and K.K. Kharbanda. 2017. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J. Gastroenterol. 23:6016-6029.
DOI
|
12 |
Hendrickson, B.A., R. Gokhale and J.H. Cho. 2002. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev. 15:79-94.
DOI
|
13 |
Kim, Y.S. J.S. Kim, S.U. Choi, J.S. Kim, H.S. Lee, S.H. Roh, Y.C. Jeong, Y.K. Kim and S.Y. Ryu. 2005. Isolation of a new saponin and cytotoxic effect of saponins from the root of Platycodon grandiflorum on human tumor cell lines. Planta Med. 71:566-568.
DOI
|
14 |
Nunes, N.S., S. Kim, M. Sundby, P. Chandran, S.R. Burks, A.H. Paz and J.A. Frank. 2018. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J. Gastroenterol. 24(38):4341-4355.
DOI
|
15 |
Park, J.H., L. Peyrin-Biroulet, M. Eisenhut and J.I. Shin. 2017. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. Autoimmun. Rev. 16(4):416-426.
DOI
|
16 |
Sands, B.E. and G.G. Kaplan. 2007. The role of TNFalpha in ulcerative colitis. J. Clin. Pharmacol. 47(8):930-941.
DOI
|
17 |
Van Uden, P., N.S. Kenneth and S. Rocha. 2008. Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem. J. 412: 477-484.
DOI
|
18 |
Danese, S., M. Sans and C. Fiocchi. 2004. Inflammatory bowel disease; the role of environmental factors. Autoimmun. Rev. 3:394-400.
DOI
|
19 |
Baumgart, D.C. and S.R. Carding. 2007. Inflammatory bowel disease: Cause and immunobiology. Lancet 369:1627-1640.
DOI
|
20 |
Choi, J.N. and W.H. Lee. 2018. An investigation of characteristics of Chinese bellflower (Platycodon grandiflorum A.) cultivated soil. Korean J. Plant Res. 31(6):660-666.
DOI
|
21 |
Domenech, E. 2006. Inflammatory bowel disease: Current therapeutic options. Digestion 73:67-76.
DOI
|
22 |
Furuta, G.T., J.R. Turner, C.T. Taylor, R.M. Hershberg, K. Comerford, S. Narravula, D.K. Podolsky and S.P. Colgan. 2001. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193(9):1027-1034.
DOI
|
23 |
Ogata, H. and T. Hibi. 2003. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharm. Des. 9:1107-1113.
DOI
|
24 |
Karhausen, J., G.T. Furuta, J. E. Tomaszewski, R. S. Johnson, S.P. Colgan and V.H. Haase. 2004. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Investig. 8:1098-1106.
|
25 |
Kim, Y.P., E.B. Lee, S.Y. Kim, D. Li, H.S. Ban, S.S. Lim, K.H. Shin and K. Ohuchi. 2001. Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Med. 67:362-364.
DOI
|
26 |
Li, Y., C. de Haar, M Chen, J. Deuring, M.M. Gerrits, R. Smits, B. Xia, E.J. Kuipers and J. van der Woude. 2010. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 59:227-235.
DOI
|
27 |
Papadakis, K.A. and S.R. Targan. 2000. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51:289-298.
DOI
|